A sequential multistage randomised clinical trial (SMART) to produce evidence to guide a
step-wise clinical approach for the treatment of ultra high risk patients and reduction of
risk for psychosis and other deleterious clinical and/or functional outcomes.
Phase:
Phase 3
Details
Lead Sponsor:
Orygen Orygen Youth Health Research Centre
Collaborators:
National Institute of Mental Health (NIMH) University of California, Davis University of California, San Francisco